...
首页> 外文期刊>Clinical otolaryngology: official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery >The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis.
【24h】

The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta-analysis.

机译:喉发育不良患者的恶性风险和间隔时间;对病例系列和荟萃分析的系统评价。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Laryngeal dysplasia is a pre-malignant condition with wide variability in rates of malignant transformation reported in the literature. The management and follow-up strategies of these lesions vary widely. OBJECTIVES: To assess the risk of and interval to malignant transformation in patients with laryngeal dysplasia, the effect of different treatment modalities on malignant transformation and the effects that risk factors such as smoking, excessive alcohol intake and histological grade may have on this. TYPE OF REVIEW: Systematic of observational studies with attempted meta-analysis. SEARCH STRATEGY: A structured search of Medline (1966 to January 2010), EMBASE (1980 to January 2010), CINAHL (1981 to January 2010) and Cochrane databases (CENTRAL, Cochrane Library, 1995 to January 2010). RESULTS: Nine hundred and forty cases from nine studies were included in the analysis. Overall malignant transformation rate was 14% (confidence interval 8, 22) and mean time to malignant transformation was 5.8 years. The malignant transformation rate is higher with increased severity of dysplasia grade - severe/CIS 30.4%versus mild/moderate 10.6% (P < 0.0002). Treatment modality did not show significant effects. CONCLUSIONS: Laryngeal dysplasia carries a significant risk of malignant transformation. This risk triples with increasing severity of dysplasia. Transformation often occurs late and is not related to the grade of dysplasia. There is little evidence, therefore, to support the early discharge of patients with mild/moderate dysplasia, which is practised by some clinicians.
机译:背景:喉管发育不良是一种恶性前病,文献报道恶性转化率差异很大。这些病变的治疗和随访策略差异很大。目的:评估喉部异型增生患者恶变的风险和间隔,不同治疗方式对恶变的影响以及吸烟,过量饮酒和组织学分级等危险因素的影响。评论类型:尝试性荟萃分析的系统观察研究。搜索策略:对Medline(1966年至2010年1月),EMBASE(1980年至2010年1月),CINAHL(1981年至2010年1月)和Cochrane数据库(CENTRAL,Cochrane图书馆,1995年至2010年1月)进行结构化搜索。结果:来自九项研究的940例病例被纳入分析。总体恶性转化率为14%(置信区间8、22),平均恶性转化时间为5.8年。恶性转化率随着不典型增生严重程度的增加而增加-重度/ CIS为30.4%,轻度/中度为10.6%(P <0.0002)。治疗方式未显示明显效果。结论:喉异型增生具有恶性转化的显着风险。随着发育异常的加剧,这种风险增加了两倍。转化通常发生在较晚的时间,与发育不良的程度无关。因此,几乎没有证据支持某些临床医生所实施的轻度/中度发育异常的患者的早期出院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号